Concepedia

Phase II trial of liposomal daunorubicin in malignant pleural mesothelioma

Jeremy Steele, Catherine A O'Doherty, Jonathan Shamash, Marie T. Evans, N.H. Gower, Marc Tischkowitz, R.M. Rudd

Annals of Oncology · 2001 · 35 citations · 6 references

DOIFull text

Open access

Concepts

References

6

Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients

David J. Sugarbaker, Raja M. Flores, Michael T. Jaklitsch et al. · Journal of Thoracic and Cardiovascular Surgery · 1999 · 986 citations · Full text

, , +15

Continuing increase in mesothelioma mortality in Britain

Julian Peto, Fiona E. Matthews, J T Hodgson et al. · The Lancet · 1995 · 573 citations

, , +11

Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin.

Parkash S. Gill, Byron M. Espina, Franco M. Muggia et al. · Journal of Clinical Oncology · 1995 · 242 citations

, , +14

Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors.

Eric A. Forssen, D M Coulter, Richard T. Proffitt · PubMed · 1992 · 185 citations

, , +15

Phase I and pharmacologie study of liposomal daunorubicin (DaunoXome)

Perry P. Guaglianone, Kenneth K. Chan, Eduardo Delaflor–Weiss et al. · Investigational New Drugs · 1994 · 81 citations

, , +7